Synopsis
Synopsis
0
EU WC
0
KDMF
0
FDF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Temaril
2. Theralen
3. Theraline
4. Trimeprazine Tartrate
1. Trimeprazine Tartrate
2. 4330-99-8
3. Trimeprazine Hemitartrate Salt
4. Nsc-17475
5. Nsc-757358
6. Prestwick_144
7. Chembl3989885
8. Hms1570j05
9. Hms3714j05
10. Trimeprazine Hemi-(+)-tartrate Salt
11. Ccg-220842
Molecular Weight | 747.0 g/mol |
---|---|
Molecular Formula | C40H50N4O6S2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 11 |
Exact Mass | 746.31717767 g/mol |
Monoisotopic Mass | 746.31717767 g/mol |
Topological Polar Surface Area | 179 Ų |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 445 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5947
Submission : 1985-08-06
Status : Inactive
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15817
Submission : 2002-01-17
Status : Active
Type : II
Certificate Number : R1-CEP 2015-165 - Rev 00
Issue Date : 2021-06-08
Type : Chemical
Substance Number : 2650
Status : Valid
Registration Number : 218MF10151
Registrant's Address : 23, rue Bossuet Z. I. de la Vigne aux Loups F-91160 LONGJUMEAU France
Initial Date of Registration : 2006-01-31
Latest Date of Registration : --
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2668
Submission : 1976-05-04
Status : Inactive
Type : II
NDC Package Code : 52952-002
Start Marketing Date : 2016-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6199
Submission : 2017-07-27
Status : Active
Type : II
Certificate Number : CEP 2022-401 - Rev 00
Issue Date : 2024-10-17
Type : Chemical
Substance Number : 2650
Status : Valid
NDC Package Code : 71554-117
Start Marketing Date : 2020-05-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6464
Submission : 2022-02-17
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Reply
02 Dec 2024
Reply
11 Jan 2024
Reply
03 Feb 2022
Reply
24 Apr 2020
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?